| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Dilated | 8 | 2022 | 244 | 0.650 |
Why?
|
| Cardiomyopathies | 6 | 2022 | 610 | 0.490 |
Why?
|
| Heart Transplantation | 7 | 2023 | 908 | 0.470 |
Why?
|
| Heart Ventricles | 4 | 2023 | 846 | 0.450 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 88 | 0.430 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2013 | 218 | 0.370 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 2016 | 92 | 0.360 |
Why?
|
| Myocardium | 9 | 2013 | 1313 | 0.330 |
Why?
|
| Heart Aneurysm | 2 | 2023 | 42 | 0.300 |
Why?
|
| Graft Rejection | 4 | 2023 | 834 | 0.280 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2011 | 435 | 0.250 |
Why?
|
| Diverticulum | 1 | 2023 | 35 | 0.230 |
Why?
|
| Biopsy | 6 | 2023 | 3443 | 0.220 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2003 | 112 | 0.220 |
Why?
|
| Aneurysm, False | 1 | 2023 | 153 | 0.200 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 778 | 0.180 |
Why?
|
| Heart Valve Diseases | 3 | 2011 | 193 | 0.180 |
Why?
|
| Aortic Valve | 3 | 2020 | 581 | 0.180 |
Why?
|
| Siderosis | 1 | 2019 | 2 | 0.170 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2019 | 10 | 0.170 |
Why?
|
| Fetal Death | 1 | 2019 | 113 | 0.160 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 167 | 0.160 |
Why?
|
| Heart | 6 | 2022 | 1223 | 0.160 |
Why?
|
| Infant, Newborn | 14 | 2022 | 8223 | 0.160 |
Why?
|
| Liver Failure | 1 | 2019 | 140 | 0.150 |
Why?
|
| Extracellular Matrix | 2 | 2011 | 554 | 0.150 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 86 | 0.150 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 259 | 0.150 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2012 | 300 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 186 | 0.140 |
Why?
|
| Infant | 15 | 2020 | 13310 | 0.140 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2016 | 16 | 0.140 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2016 | 30 | 0.140 |
Why?
|
| Iron | 1 | 2019 | 376 | 0.130 |
Why?
|
| Enteritis | 1 | 2016 | 65 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 254 | 0.130 |
Why?
|
| Heart Diseases | 2 | 2013 | 732 | 0.130 |
Why?
|
| Immunization, Passive | 1 | 2016 | 172 | 0.130 |
Why?
|
| Myocarditis | 2 | 2010 | 190 | 0.130 |
Why?
|
| Sequence Deletion | 2 | 2016 | 875 | 0.130 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 208 | 0.130 |
Why?
|
| Hemangioma, Capillary | 1 | 2015 | 35 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 250 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 998 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 2 | 2022 | 492 | 0.120 |
Why?
|
| Endocardial Fibroelastosis | 2 | 2010 | 12 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 467 | 0.120 |
Why?
|
| Camellia sinensis | 1 | 2013 | 3 | 0.120 |
Why?
|
| HIV Infections | 2 | 2004 | 2134 | 0.120 |
Why?
|
| Muscle Proteins | 2 | 2022 | 549 | 0.120 |
Why?
|
| Catheterization | 1 | 2016 | 410 | 0.120 |
Why?
|
| Anti-Obesity Agents | 1 | 2013 | 30 | 0.120 |
Why?
|
| Parvovirus B19, Human | 2 | 2010 | 39 | 0.110 |
Why?
|
| Parvoviridae Infections | 2 | 2010 | 38 | 0.110 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 279 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 330 | 0.110 |
Why?
|
| Fetal Therapies | 1 | 2013 | 79 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2012 | 3 | 0.110 |
Why?
|
| Myocytes, Cardiac | 5 | 2012 | 764 | 0.110 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 111 | 0.110 |
Why?
|
| Liver Failure, Acute | 1 | 2013 | 88 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2012 | 41 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 280 | 0.100 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2013 | 193 | 0.100 |
Why?
|
| Humans | 40 | 2023 | 261506 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2013 | 215 | 0.100 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2015 | 324 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 598 | 0.100 |
Why?
|
| Mucinoses | 1 | 2010 | 1 | 0.090 |
Why?
|
| Mutation | 4 | 2013 | 15179 | 0.090 |
Why?
|
| RNA-Binding Proteins | 2 | 2007 | 984 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2011 | 134 | 0.090 |
Why?
|
| Child | 14 | 2023 | 29154 | 0.090 |
Why?
|
| Telomere | 1 | 2013 | 505 | 0.090 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2011 | 110 | 0.090 |
Why?
|
| Myocardial Stunning | 1 | 2009 | 21 | 0.090 |
Why?
|
| Genome, Viral | 1 | 2010 | 155 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2016 | 581 | 0.090 |
Why?
|
| Codon, Nonsense | 2 | 2012 | 164 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2008 | 133 | 0.090 |
Why?
|
| Pulmonary Valve | 1 | 2010 | 87 | 0.090 |
Why?
|
| Child, Preschool | 11 | 2011 | 16273 | 0.090 |
Why?
|
| Waiting Lists | 1 | 2011 | 263 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2011 | 1697 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 1084 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 1005 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2009 | 136 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 223 | 0.080 |
Why?
|
| Heart Failure | 1 | 2022 | 2516 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 674 | 0.080 |
Why?
|
| Biliary Atresia | 1 | 2011 | 191 | 0.080 |
Why?
|
| Mice, Transgenic | 7 | 2012 | 4143 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 546 | 0.080 |
Why?
|
| Liver | 2 | 2019 | 2961 | 0.080 |
Why?
|
| Zidovudine | 1 | 2007 | 40 | 0.080 |
Why?
|
| Lung | 2 | 2016 | 3151 | 0.080 |
Why?
|
| Male | 22 | 2020 | 123000 | 0.080 |
Why?
|
| Actin Cytoskeleton | 2 | 2022 | 82 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 150 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2010 | 349 | 0.070 |
Why?
|
| Desmosomes | 1 | 2006 | 28 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2007 | 132 | 0.070 |
Why?
|
| Desmoplakins | 1 | 2006 | 22 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2012 | 1011 | 0.070 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2006 | 29 | 0.070 |
Why?
|
| Cholestasis | 1 | 2008 | 203 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 101 | 0.070 |
Why?
|
| Abscess | 2 | 2004 | 177 | 0.070 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2005 | 5 | 0.070 |
Why?
|
| Myotonic Dystrophy | 1 | 2007 | 151 | 0.070 |
Why?
|
| Echocardiography | 3 | 2012 | 1182 | 0.070 |
Why?
|
| Intellectual Disability | 1 | 2013 | 1032 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 2007 | 584 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 499 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2012 | 1152 | 0.070 |
Why?
|
| Laryngeal Diseases | 1 | 2004 | 49 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2010 | 686 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 941 | 0.060 |
Why?
|
| Anti-HIV Agents | 1 | 2007 | 350 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2005 | 195 | 0.060 |
Why?
|
| Cardiac Catheterization | 2 | 2023 | 687 | 0.060 |
Why?
|
| Female | 19 | 2023 | 141928 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2006 | 244 | 0.060 |
Why?
|
| Failure to Thrive | 1 | 2004 | 91 | 0.060 |
Why?
|
| Endophthalmitis | 1 | 2004 | 84 | 0.060 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2004 | 79 | 0.060 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2005 | 192 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2006 | 239 | 0.060 |
Why?
|
| Adenovirus Infections, Human | 1 | 2003 | 56 | 0.060 |
Why?
|
| Laryngectomy | 1 | 2004 | 242 | 0.060 |
Why?
|
| Adolescent | 11 | 2016 | 31252 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 128 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2008 | 830 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2011 | 1112 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2010 | 1459 | 0.050 |
Why?
|
| Aspergillosis | 1 | 2004 | 246 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 4320 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 42 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2010 | 2022 | 0.050 |
Why?
|
| Ultrasonography | 3 | 2015 | 1863 | 0.050 |
Why?
|
| Time Factors | 2 | 2013 | 12926 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2023 | 4744 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2004 | 288 | 0.050 |
Why?
|
| Organ Size | 1 | 2003 | 690 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 226 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2003 | 234 | 0.050 |
Why?
|
| Pregnancy | 3 | 2023 | 7573 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2008 | 6150 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2004 | 698 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 2008 | 1429 | 0.050 |
Why?
|
| Mice | 8 | 2022 | 34495 | 0.040 |
Why?
|
| Syndrome | 2 | 2016 | 1351 | 0.040 |
Why?
|
| HIV-1 | 1 | 2004 | 653 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2023 | 37905 | 0.040 |
Why?
|
| Risk Factors | 5 | 2018 | 17523 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 473 | 0.040 |
Why?
|
| Cytokines | 1 | 2008 | 2809 | 0.040 |
Why?
|
| Stillbirth | 1 | 2019 | 82 | 0.040 |
Why?
|
| Perinatal Care | 1 | 2019 | 63 | 0.040 |
Why?
|
| YY1 Transcription Factor | 1 | 2016 | 18 | 0.040 |
Why?
|
| Enterovirus | 2 | 2010 | 63 | 0.040 |
Why?
|
| DNA, Viral | 2 | 2010 | 694 | 0.040 |
Why?
|
| Electrocardiography | 2 | 2012 | 1145 | 0.040 |
Why?
|
| Aorta | 1 | 2020 | 692 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2016 | 146 | 0.030 |
Why?
|
| Animals | 8 | 2022 | 59536 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 194 | 0.030 |
Why?
|
| Duodenum | 1 | 2016 | 149 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 633 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 691 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2016 | 32848 | 0.030 |
Why?
|
| Phenotype | 3 | 2012 | 6295 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2013 | 104 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 2013 | 44 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2013 | 69 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 143 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 7548 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 111 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2013 | 110 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 829 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 2422 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2013 | 250 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 2 | 2011 | 476 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2008 | 12873 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 392 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 2012 | 23 | 0.030 |
Why?
|
| Rats | 2 | 2012 | 6086 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 2171 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 11538 | 0.030 |
Why?
|
| Adult | 6 | 2023 | 77950 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2013 | 186 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 701 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2012 | 6100 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 2843 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 252 | 0.030 |
Why?
|
| Glomerular Basement Membrane | 1 | 2011 | 22 | 0.020 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2011 | 26 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2011 | 61 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 844 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 3203 | 0.020 |
Why?
|
| ADAMTS13 Protein | 1 | 2011 | 92 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2012 | 234 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2007 | 1620 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2010 | 34 | 0.020 |
Why?
|
| Flurandrenolone | 1 | 2010 | 1 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 590 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 2010 | 17 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2010 | 46 | 0.020 |
Why?
|
| Betamethasone | 1 | 2010 | 16 | 0.020 |
Why?
|
| LIM Domain Proteins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2011 | 109 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2011 | 259 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 829 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 291 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 462 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 745 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12221 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 598 | 0.020 |
Why?
|
| Young Adult | 2 | 2023 | 21445 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 248 | 0.020 |
Why?
|
| Adenoviridae Infections | 1 | 2010 | 125 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2013 | 6869 | 0.020 |
Why?
|
| Age Factors | 2 | 2013 | 5377 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1471 | 0.020 |
Why?
|
| Sepsis | 1 | 2015 | 652 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2011 | 263 | 0.020 |
Why?
|
| Mechlorethamine | 1 | 2008 | 51 | 0.020 |
Why?
|
| Procarbazine | 1 | 2008 | 69 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 168 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 2483 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 360 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1293 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2232 | 0.020 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2007 | 36 | 0.020 |
Why?
|
| Vinblastine | 1 | 2008 | 453 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 1890 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2007 | 46 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2008 | 100 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 1338 | 0.020 |
Why?
|
| Tretinoin | 1 | 2010 | 623 | 0.020 |
Why?
|
| Bleomycin | 1 | 2008 | 467 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 649 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 603 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 2063 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 752 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 448 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 4233 | 0.020 |
Why?
|
| Troponin I | 1 | 2007 | 127 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 1062 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 2007 | 144 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 300 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2006 | 54 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 717 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 15862 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 935 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2010 | 764 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Caffeine | 1 | 2006 | 87 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2005 | 27 | 0.020 |
Why?
|
| Prednisone | 1 | 2008 | 984 | 0.020 |
Why?
|
| CELF Proteins | 1 | 2005 | 14 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 6089 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 151 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 255 | 0.020 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2005 | 62 | 0.020 |
Why?
|
| Penetrance | 1 | 2005 | 126 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 3438 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 5539 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 225 | 0.020 |
Why?
|
| Vincristine | 1 | 2008 | 1511 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 1900 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 2005 | 161 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4892 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2004 | 307 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2012 | 1664 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2008 | 1144 | 0.010 |
Why?
|
| NADPH Oxidases | 1 | 2004 | 146 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 509 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2008 | 1038 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 741 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 1062 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 483 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 7551 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 5114 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 303 | 0.010 |
Why?
|
| Apoptosis | 2 | 2007 | 7591 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 3260 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 1163 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 1538 | 0.010 |
Why?
|
| Remission Induction | 1 | 2008 | 3569 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2004 | 206 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2008 | 3005 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 3536 | 0.010 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2004 | 430 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 6942 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2008 | 3842 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 3343 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 2283 | 0.010 |
Why?
|
| Texas | 1 | 2011 | 6311 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6207 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 2139 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 2074 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 5673 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2003 | 398 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 1581 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2004 | 834 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 7702 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 1152 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 1375 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 1270 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 8865 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 6682 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 7222 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 9244 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 21713 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 14551 | 0.010 |
Why?
|